@article {Kary405, author = {S Kary and M Worm and H Audring and D Huscher and M Renelt and H S{\"o}rensen and E St{\"a}nder and U Maa{\ss} and H Lee and W Sterry and G-R Burmester}, title = {New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists}, volume = {65}, number = {3}, pages = {405--407}, year = {2006}, doi = {10.1136/ard.2005.037424}, publisher = {BMJ Publishing Group Ltd}, abstract = {Background: Blockage of tumour necrosis factor α (TNFα) is highly effective in rheumatic diseases, especially in rheumatoid arthritis (RA), ankylosing spondylitis, and psoriatic arthritis. Furthermore, TNFα antagonists have also been shown to significantly reduce psoriatic skin lesions. Case reports: A series of nine patients with RA who were treated with different types of TNFα antagonists and who unexpectedly developed either a new onset or an exacerbation of psoriatic skin lesions are reported}, issn = {0003-4967}, URL = {https://ard.bmj.com/content/65/3/405}, eprint = {https://ard.bmj.com/content/65/3/405.full.pdf}, journal = {Annals of the Rheumatic Diseases} }